Ignite Creation Date:
2025-12-25 @ 2:27 AM
Ignite Modification Date:
2026-02-17 @ 10:40 PM
Study NCT ID:
NCT02315534
Status:
COMPLETED
Last Update Posted:
2023-11-15
First Post:
2014-12-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of BBI608 in Combination With Temozolomide in Adult Patients With Recurrent or Progressed Glioblastoma
Sponsor:
Sumitomo Pharma America, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-03
Start Date Type:
None
Primary Completion Date:
2018-10-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-06-24
Completion Date Type:
ACTUAL
First Submit Date:
2014-12-09
First Submit QC Date:
None
Study First Post Date:
2014-12-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-04-07
Results First Submit QC Date:
None
Results First Post Date:
2021-09-24
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-11-13
Last Update Post Date:
2023-11-15
Last Update Post Date Type:
ACTUAL